Table 2 Univariate analysis of the significance of different prognostic variables in nasopharyngeal carcinoma
Factors | DMFS | OS | ||||
|---|---|---|---|---|---|---|
P value | HR | 95% CI | P value | HR | 95% CI | |
Age (>50 yr vs. ≤50 yr) | 0.02 | 1.90 | 1.09–3.35 | <0.01 | 2.15 | 1.22–3.81 |
Sex (female vs. male) | 0.82 | 0.93 | 1.48–1.78 | 0.66 | 0.86 | 0.44–1.69 |
Chemotherapy (yes vs. no) | 0.14 | 1.78 | 0.83–3.79 | 0.26 | 1.52 | 0.73–3.13 |
Radiotherapy (IMRT vs.2D-RT) | 0.99 | 1.00 | 0.80–1.25 | 0.93 | 1.01 | 0.81–1.26 |
T stage (T3–4 vs. T1–2) | 0.13 | 1.55 | 0.88–2.74 | 0.06 | 1.77 | 0.99–3.18 |
N stage (N2–3 vs. N0–1) | 0.02 | 1.98 | 1.13–3.47 | 0.01 | 2.06 | 1.17–3.63 |
Clinical stage (III-IV vs. I-II) | 0.01 | 2.52 | 1.22–5.19 | <0.01 | 2.78 | 1.30–5.95 |
MTA1 expression (high vs. low) | <0.01 | 2.25 | 1.25–4.05 | <0.01 | 2.19 | 1.21–3.97 |